Correlation Between Talanx AG and OptiNose
Can any of the company-specific risk be diversified away by investing in both Talanx AG and OptiNose at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talanx AG and OptiNose into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talanx AG and OptiNose, you can compare the effects of market volatilities on Talanx AG and OptiNose and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talanx AG with a short position of OptiNose. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talanx AG and OptiNose.
Diversification Opportunities for Talanx AG and OptiNose
Excellent diversification
The 3 months correlation between Talanx and OptiNose is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Talanx AG and OptiNose in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OptiNose and Talanx AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talanx AG are associated (or correlated) with OptiNose. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OptiNose has no effect on the direction of Talanx AG i.e., Talanx AG and OptiNose go up and down completely randomly.
Pair Corralation between Talanx AG and OptiNose
Assuming the 90 days horizon Talanx AG is expected to generate 68.72 times less return on investment than OptiNose. But when comparing it to its historical volatility, Talanx AG is 125.1 times less risky than OptiNose. It trades about 0.27 of its potential returns per unit of risk. OptiNose is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 1,050 in OptiNose on October 9, 2024 and sell it today you would lose (474.00) from holding OptiNose or give up 45.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Talanx AG vs. OptiNose
Performance |
Timeline |
Talanx AG |
OptiNose |
Talanx AG and OptiNose Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Talanx AG and OptiNose
The main advantage of trading using opposite Talanx AG and OptiNose positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talanx AG position performs unexpectedly, OptiNose can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will offset losses from the drop in OptiNose's long position.Talanx AG vs. ONWARD MEDICAL BV | Talanx AG vs. PEPTONIC MEDICAL | Talanx AG vs. CREO MEDICAL GRP | Talanx AG vs. AFFLUENT MEDICAL SAS |
OptiNose vs. Superior Plus Corp | OptiNose vs. NMI Holdings | OptiNose vs. SIVERS SEMICONDUCTORS AB | OptiNose vs. Talanx AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
CEOs Directory Screen CEOs from public companies around the world |